Skip to content

SYNERGY™ XD H7493941808220Recalls & reported problems

Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant

All models of SYNERGY XD (65)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
7
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 08714729980704), received between May 26, 2021 and Feb 10, 2026 — classified as 1 injury, 6 malfunctions.

The most frequently reported specific device problem is “Break” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break3
  • Device Dislodged or Dislocated2
  • Difficult to Advance2
  • Material Deformation2
  • Difficult to Remove1
  • Failure to Advance1
  • Material Separation1
  • Nonstandard Device1

Patient problems

  • No Clinical Signs, Symptoms or Conditions7

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 10, 2026Nonstandard Device; Material Separation

    IT WAS REPORTED THAT MATERIAL SEPARATION OCCURRED. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS SELECTED FOR TREATMENT; HOWEVER, A STENT DETACHMENT OCCURRED. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24309968 ↗
  • MalfunctionAug 29, 2025Failure to Advance; Device Dislodged or Dislocated; Failure to Advance; Device Dislodged or Dislocated

    IT WAS REPORTED THAT STENT DISLODGMENT OCCURRED. THE PATIENT PRESENTED WITH CORONARY ARTERY DISEASE AND UNDERWENT A PERCUTANEOUS CORONARY INTERVENTION. A 2.25 X 8MM SYNERGY? XD DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. UPON ATTEMPTED REMOVAL, THE STENT BECAME DISLODGED FROM THE DELIVERY SYSTEM AND WAS NO LONGER POSITIONED ON THE BALLOON. THE DISLODGED STENT WAS SUCCESSFULLY RETRIEVED ALONG WITH THE DELIVERY SYSTEM. THE PROCEDURE WAS COMPLETED USING A NEW STENT. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22927028 ↗
  • MalfunctionJun 3, 2024Break; Break

    IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE 80% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MILDLY CALCIFIED CIRCUMFLEX ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT (DES) WAS OPENED OUT OF THE PACKAGE, BUT THE SHAFT WAS VISIBLY BROKEN AT PROXIMAL TO THE HUB. ANOTHER 2.25 X 8MM SYNERGY DES WAS OPENED AND ADVANCED BUT IT FAILED TO CROSS THE LESION. HOWEVER, WHEN THE PHYSICIAN ATTEMPTED TO TWIST THE STENT, IT DID NOT LOOK RIGHT, AND UPON REMOVAL FROM THE SHEATH, THE SHAFT WAS ALSO BROKEN AT PROXIMAL TO THE STENT BALLOON. THE PROCEDURE WAS COMPLETED WITH A NON-BOSTON SCIENTIFIC DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19445844 ↗
  • MalfunctionDec 22, 2022Break; Difficult to Advance; Material Deformation; Break; Difficult to Advance; Material Deformation

    IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN THE SEVERELY TORTUOUS AND MILDLY CALCIFIED LEFT ANTERIOR DESCENDING ARTERY (LAD). A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT (DES) WAS PREPARED TO BE DELIVERED. HOWEVER, THE SHAFT GOT KINKED OUTSIDE OF THE HEMOSTASIS VALVE. UPON CONTINUOUS ATTEMPT TO DELIVER THE DEVICE, THE PROXIMAL PORTION OF DELIVERY SHAFT BROKE OFF WHEN TRYING TO DELIVER AROUND THE HARD BEND. THE STENT AND REMAINING SHAFT WERE REMOVED WITH NO OTHER COMPLICATIONS. THE DETACHED PORTION WAS SIMPLY PULLED OUT AND THE PROCEDURE WAS COMPLETED WITH A NON-BOSTON SCIENTIFIC DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16038234 ↗
  • MalfunctionNov 14, 2022Break; Break

    IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE PATIENT PRESENTED WITH CORONARY ARTERIAL DISEASE AND UNDERWENT PERCUTANEOUS CORONARY INTERVENTION. THE TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MILDLY CALCIFIED LEFT CIRCUMFLEX ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED THROUGH A GUIDE CATHETER AND GUIDEZILLA GUIDE EXTENSION CATHETER. THE PHYSICIAN DECIDED TO REMOVE THE GUIDEZILLA TO MAKE THE STENT DELIVERY EASIER. HOWEVER, IT WAS NOTED THAT WHEN THE STENT WAS PULLED OUT OF THE BODY, THE SHAFT BROKE IN HALF. THE BROKEN SHAFT WAS PULLED OUT INTACT. A 2.50 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. UPON REMOVAL, IT WAS NOTED THAT THE STENT WAS FRAYED. ANOTHER 2.50 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15788449 ↗
  • InjuryAug 24, 2022Difficult to Remove; Device Dislodged or Dislocated; Difficult to Remove; Device Dislodged or Dislocated

    IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. THE TARGET LESION WAS LOCATED IN THE LEFT ANTERIOR DESCENDING ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS SELECTED FOR USE. HOWEVER, IT WAS NOTED THAT THE STENT DETACHED FROM THE DELIVERY SYSTEM. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT STATUS WAS STABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15287080 ↗
  • MalfunctionMay 26, 2021Positioning Failure; Difficult to Advance; Material Deformation; Positioning Failure; Difficult to Advance; Material Deformation

    IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE 100% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MILDLY CALCIFIED DISTAL RIGHT CORONARY ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED BUT RESISTANCE WAS FELT AND COULD NOT INFLATE THE STENT. THE SHAFT WAS BENT DURING INSERTION. HOWEVER, UPON REMOVAL, THE STENT WAS CAUGHT AT THE EDGE WITH GUIDEZILLA GUIDE EXTENSION CATHETER AND WAS DEFORMED. THE DEVICE WAS REMOVED AND THE PROCEDURE WAS COMPLETED. THERE WERE NO PATIENT COMPLICATIONS NOR INJURIES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11891376 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page